| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |